We are live on ! Find out more
FG

Fairman Group Portfolio holdings

AUM $127M Turnover 8.16%
1-Year Est. Return 6.28%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+6.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$2.6M
Cap. Flow
+$1.24M
Cap. Flow %
1%
Top 10 Hldgs %
69.52%
Holding
284
New
27
Increased
59
Reduced
25
Closed
10
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.27%
2 Technology 20.52%
3 Financials 10.78%
4 Healthcare 5.34%
5 Consumer Discretionary 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CCK icon
226
Crown Holdings
CCK
$12.4B
$2.32K ﹤0.01%
24
– –
2023 Q4
7 quarters
FLJP icon
227
Franklin FTSE Japan ETF
FLJP
$4.19B
$2.32K ﹤0.01%
67
– –
2024 Q2
5 quarters
CNI icon
228
Canadian National Railway
CNI
$72.9B
$2.26K ﹤0.01%
24
– –
2023 Q4
7 quarters
CF icon
229
CF Industries
CF
$18.1B
$2.24K ﹤0.01%
25
– –
2023 Q4
7 quarters
TRN icon
230
Trinity Industries
TRN
$2.03B
$2.24K ﹤0.01%
80
– –
2023 Q4
7 quarters
EBAY icon
231
eBay
EBAY
$54.7B
$2K ﹤0.01%
22
– –
2023 Q4
7 quarters
MDT icon
232
Medtronic
MDT
$122B
$1.92K ﹤0.01%
20
– –
2023 Q4
7 quarters
UL icon
233
Unilever
UL
$139B
$1.54K ﹤0.01%
23
– –
2023 Q4
7 quarters
DEO icon
234
Diageo
DEO
$52.3B
$1.53K ﹤0.01%
16
– –
2023 Q4
7 quarters
PHO icon
235
Invesco Water Resources ETF
PHO
$1.95B
$1.31K ﹤0.01%
18
– –
2023 Q4
7 quarters
PPG icon
236
PPG Industries
PPG
$24B
$1.26K ﹤0.01%
12
– –
2023 Q4
7 quarters
GEV icon
237
GE Vernova
GEV
$247B
$1.23K ﹤0.01%
2
– –
2024 Q2
5 quarters
BTI icon
238
British American Tobacco
BTI
$125B
$1.17K ﹤0.01%
22
– –
2023 Q4
7 quarters
VRTS icon
239
Virtus Investment Partners
VRTS
$814M
$1.14K ﹤0.01%
6
– –
2023 Q4
7 quarters
CBSH icon
240
Commerce Bancshares
CBSH
$7.97B
$1.08K ﹤0.01%
19
– –
2023 Q4
7 quarters
CARR icon
241
Carrier Global
CARR
$45.3B
$1.01K ﹤0.01%
17
– –
2023 Q4
7 quarters
DOC icon
242
Healthpeak Properties
DOC
$13.1B
$977 ﹤0.01%
51
– –
2025 Q1
2 quarters
TAP icon
243
Molson Coors Class B
TAP
$7.28B
$905 ﹤0.01%
20
– –
2023 Q4
7 quarters
BABA icon
244
Alibaba
BABA
$276B
$894 ﹤0.01%
5
– –
2023 Q4
7 quarters
GSK icon
245
GSK
GSK
$98.2B
$872 ﹤0.01%
20
– –
2023 Q4
7 quarters
BIIB icon
246
Biogen
BIIB
$34.8B
$840 ﹤0.01%
6
– –
2023 Q4
7 quarters
CMA icon
247
DELISTED
Comerica
CMA
$762 ﹤0.01%
11
– –
2023 Q4
7 quarters
OTIS icon
248
Otis Worldwide
OTIS
$26.8B
$731 ﹤0.01%
8
– –
2023 Q4
7 quarters
BAX icon
249
Baxter International
BAX
$13.3B
$688 ﹤0.01%
30
– –
2023 Q4
7 quarters
TAK icon
250
Takeda Pharmaceutical
TAK
$62.1B
$659 ﹤0.01%
45
– –
2023 Q4
7 quarters

Similar funds

Fairman Group's Q3 2025 Portfolio in Review

As of Q3 2025, Fairman Group held 284 positions worth $124M, up 2.1% from $122M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Fairman Group's Q3 2025 filing shows 27 new, 59 increased, 25 reduced and 10 closed positions. Its largest new stake was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M. The largest sale was Essent Group, an estimated $1.46M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 54% a quarter earlier, followed by Technology and Financials.

  • Fairman Group's largest Q3 2025 buy was Diamond Hill Large Cap Concentrated ETF: 91,273 shares worth $1.19M.
  • Fairman Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $2.18M increase.
  • Fairman Group's biggest Q3 2025 reduction was Essent Group, cutting an estimated $1.46M.
  • Fairman Group fully exited State Street SPDR Portfolio Developed World ex-US ETF in Q3 2025, selling an estimated $75.8K.
  • Fairman Group's ten largest holdings make up 70% of its $124M portfolio in Q3 2025.
  • Fairman Group opened 27 new positions and closed 10 in Q3 2025.
  • Fairman Group's portfolio value rose 2.1% quarter-over-quarter to $124M.

Based on Fairman Group's 13F filing for Q3 2025, filed 31 Oct 2025.